[Interval therapy of migraine. Pharmacological bases].
A quite heterogenous variety of drugs is used for the prophylactic treatment of patients with severe migraine. These drugs may prove effective in preventing migraine attacks due to two different pharmacological effects: a reduction of platelets' aggregability and/or an effect on blood vessels tone. The latter effect may be characterized by a decrease in reactivity, i.e. vasoconstriction as well as an overshooting vasodilation is prevented. The vascular tone is stabilized.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D001241:Aspirin / Q000494:pharmacology / Q000627:therapeutic use; D001808:Blood Vessels / Q000502:physiology; D002121:Calcium Channel Blockers / Q000494:pharmacology / Q000627:therapeutic use; D002560:Cerebrovascular Circulation / Q000187:drug effects; D006801:Humans; D008833:Microcirculation / Q000187:drug effects; D008881:Migraine Disorders / Q000188:drug therapy* / Q000209:etiology; D008954:Models, Biological; D010974:Platelet Aggregation / Q000187:drug effects; D012702:Serotonin Antagonists / Q000494:pharmacology / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D012702:Serotonin Antagonists; D001241:Aspirin
Intervalltherapie der Migräne. Pharmakologische Grundlagen.